| Gale, 201118 | Attitudes of patients and GPs towards medication for primary prevention of CVD after they had received detailed information about CVD risk and the absolute benefits of preventive medicine. | Cardiovascular preventive drugs (statin and antihypertensive drugs) | 13 | 17 | Qualitative | Patients: face to face interviewsGPs: interviews | Thematic analysis | Good |
| Turner, 201334 | Reasons for the variation in statin uptake by high risk patients | Statin | 4 | 28 | Qualitative | Patients: 10 minutes telephone interviews.GPs: 30 minutes face to face interviews. | Thematic analysis | Fair |
| Virdee, 201332 | Primary care physicians’ and practice nurses’ attitude towards using the polypill for CVD prevention | Polypill | 16 (11 physicians, five practice nurses) | – | Qualitative | Semi-structured interviews and transcribed verbatim. | Thematic analysis. | Good |
| Virdee, 201533 | Patient attitudes about the use of a polypill for CVD prevention | Polypill | – | 17 | Qualitative | Semi-structured interviews. | Thematic analysis. | Good |
| Sweden |
| Hultberg, 201231 | GPs’ descriptions of their thoughts and actions when prescribing cardiovascular preventive drugs | Cardiovascular preventive drugs (no mention of specific drugs) | 14 | – | Qualitative | Group interviews of GPs practising together. | Qualitative content analysis. | Good |